Picture
SEARCH
What are you looking for?
Need help finding what you are looking for? Contact Us
Compare

PUBLISHER: QYResearch | PRODUCT CODE: 1764400

Cover Image

PUBLISHER: QYResearch | PRODUCT CODE: 1764400

Global Small Molecule CMO and CDMO Market Insights, Forecast to 2031

PUBLISHED:
PAGES: 194 Pages
DELIVERY TIME: 2-3 business days
SELECT AN OPTION
PDF (Single User License)
USD 4900
PDF (Multi User License)
USD 7350
PDF (Enterprise User License)
USD 9800

Add to Cart

This research report focuses on the Small Molecule CMO and CDMO Market. It analyzes market size, trends and demand forecasts, as well as growth factors and challenges. The report provides market data breakdowns by type, application, company, and region, in addition to competitive landscape and key company profiles.

TABLE OF CONTENTS

1 Report Overview

  • 1.1 Study Scope
  • 1.2 Market Analysis by Type
    • 1.2.1 Global Small Molecule CMO and CDMO Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
    • 1.2.2 Molecular Drug Intermediates
    • 1.2.3 API
    • 1.2.4 Prepared Products
  • 1.3 Market by Application
    • 1.3.1 Global Small Molecule CMO and CDMO Market Share by Application: 2020 VS 2024 VS 2031
    • 1.3.2 Clinical
    • 1.3.3 Commercial
  • 1.4 Assumptions and Limitations
  • 1.5 Study Objectives
  • 1.6 Years Considered

2 Global Growth Trends

  • 2.1 Global Small Molecule CMO and CDMO Market Perspective (2020-2031)
  • 2.2 Global Small Molecule CMO and CDMO Growth Trends by Region
    • 2.2.1 Global Small Molecule CMO and CDMO Market Size by Region: 2020 VS 2024 VS 2031
    • 2.2.2 Small Molecule CMO and CDMO Market Size by Region (2020-2031)
  • 2.3 Small Molecule CMO and CDMO Market Dynamics
    • 2.3.1 Small Molecule CMO and CDMO Industry Trends
    • 2.3.2 Small Molecule CMO and CDMO Market Drivers
    • 2.3.3 Small Molecule CMO and CDMO Market Challenges
    • 2.3.4 Small Molecule CMO and CDMO Market Restraints

3 Competition Landscape by Key Players

  • 3.1 Global Revenue Small Molecule CMO and CDMO by Players
    • 3.1.1 Global Small Molecule CMO and CDMO Revenue by Players (2020-2025)
    • 3.1.2 Global Small Molecule CMO and CDMO Revenue Market Share by Players (2020-2025)
  • 3.2 Global Small Molecule CMO and CDMO Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
  • 3.3 Global Key Players of Small Molecule CMO and CDMO, Ranking by Revenue, 2023 VS 2024 VS 2025
  • 3.4 Global Market Concentration Ratio
    • 3.4.1 Global Small Molecule CMO and CDMO Market Concentration Ratio (CR5 and HHI)
    • 3.4.2 Global Top 10 and Top 5 Companies by Small Molecule CMO and CDMO Revenue in 2024
  • 3.5 Global Key Players of Small Molecule CMO and CDMO Head office and Area Served
  • 3.6 Global Key Players of Small Molecule CMO and CDMO, Product and Application
  • 3.7 Global Key Players of Small Molecule CMO and CDMO, Date of Enter into This Industry
  • 3.8 Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Type

  • 4.1 Global Small Molecule CMO and CDMO Historic Market Size by Type (2020-2025)
  • 4.2 Global Small Molecule CMO and CDMO Forecasted Market Size by Type (2026-2031)

5 Breakdown Data by Application

  • 5.1 Global Small Molecule CMO and CDMO Historic Market Size by Application (2020-2025)
  • 5.2 Global Small Molecule CMO and CDMO Forecasted Market Size by Application (2026-2031)

6 North America

  • 6.1 North America Small Molecule CMO and CDMO Market Size (2020-2031)
  • 6.2 North America Market Size by Type
    • 6.2.1 North America Small Molecule CMO and CDMO Market Size by Type (2020-2031)
    • 6.2.2 North America Small Molecule CMO and CDMO Market Share by Type (2020-2031)
  • 6.3 North America Market Size by Application
    • 6.3.1 North America Small Molecule CMO and CDMO Market Size by Application (2020-2031)
    • 6.3.2 North America Small Molecule CMO and CDMO Market Share by Application (2020-2031)
  • 6.4 North America Market Size by Country
    • 6.4.1 North America Small Molecule CMO and CDMO Market Size by Country: 2020 VS 2024 VS 2031
    • 6.4.2 North America Small Molecule CMO and CDMO Market Size by Country (2020-2031)
    • 6.4.3 United States
    • 6.4.4 Canada

7 Europe

  • 7.1 Europe Small Molecule CMO and CDMO Market Size (2020-2031)
  • 7.2 Europe Market Size by Type
    • 7.2.1 Europe Small Molecule CMO and CDMO Market Size by Type (2020-2031)
    • 7.2.2 Europe Small Molecule CMO and CDMO Market Share by Type (2020-2031)
  • 7.3 Europe Market Size by Application
    • 7.3.1 Europe Small Molecule CMO and CDMO Market Size by Application (2020-2031)
    • 7.3.2 Europe Small Molecule CMO and CDMO Market Share by Application (2020-2031)
  • 7.4 Europe Market Size by Country
    • 7.4.1 Europe Small Molecule CMO and CDMO Market Size by Country: 2020 VS 2024 VS 2031
    • 7.4.2 Europe Small Molecule CMO and CDMO Market Size by Country (2020-2025)
    • 7.4.3 Germany
    • 7.4.4 France
    • 7.4.5 U.K.
    • 7.4.6 Italy
    • 7.4.7 Russia
    • 7.4.8 Nordic Countries

8 China

  • 8.1 China Small Molecule CMO and CDMO Market Size (2020-2031)
  • 8.2 China Market Size by Type
    • 8.2.1 China Small Molecule CMO and CDMO Market Size by Type (2020-2031)
    • 8.2.2 China Small Molecule CMO and CDMO Market Share by Type (2020-2031)
  • 8.3 China Market Size by Application
    • 8.3.1 China Small Molecule CMO and CDMO Market Size by Application (2020-2031)
    • 8.3.2 China Small Molecule CMO and CDMO Market Share by Application (2020-2031)

9 Asia (excluding China)

  • 9.1 Asia Small Molecule CMO and CDMO Market Size (2020-2031)
  • 9.2 Asia Market Size by Type
    • 9.2.1 Asia Small Molecule CMO and CDMO Market Size by Type (2020-2031)
    • 9.2.2 Asia Small Molecule CMO and CDMO Market Share by Type (2020-2031)
  • 9.3 Asia Market Size by Application
    • 9.3.1 Asia Small Molecule CMO and CDMO Market Size by Application (2020-2031)
    • 9.3.2 Asia Small Molecule CMO and CDMO Market Share by Application (2020-2031)
  • 9.4 Asia Market Size by Region
    • 9.4.1 Asia Small Molecule CMO and CDMO Market Size by Region: 2020 VS 2024 VS 2031
    • 9.4.2 Asia Small Molecule CMO and CDMO Market Size by Region (2020-2031)
    • 9.4.3 Japan
    • 9.4.4 South Korea
    • 9.4.5 China Taiwan
    • 9.4.6 Southeast Asia
    • 9.4.7 India
    • 9.4.8 Australia

10 Middle East, Africa, and Latin America

  • 10.1 Middle East, Africa, and Latin America Small Molecule CMO and CDMO Market Size (2020-2031)
  • 10.2 Middle East, Africa, and Latin America Market Size by Type
    • 10.2.1 Middle East, Africa, and Latin America Small Molecule CMO and CDMO Market Size by Type (2020-2031)
    • 10.2.2 Middle East, Africa, and Latin America Small Molecule CMO and CDMO Market Share by Type (2020-2031)
  • 10.3 Middle East, Africa, and Latin America Market Size by Application
    • 10.3.1 Middle East, Africa, and Latin America Small Molecule CMO and CDMO Market Size by Application (2020-2031)
    • 10.3.2 Middle East, Africa, and Latin America Market Share by Application (2020-2031)
  • 10.4 Middle East, Africa, and Latin America Market Size by Country
    • 10.4.1 Middle East, Africa, and Latin America Small Molecule CMO and CDMO Market Size by Country: 2020 VS 2024 VS 2031
    • 10.4.2 Middle East, Africa, and Latin America Small Molecule CMO and CDMO Market Size by Country (2020-2031)
    • 10.4.3 Brazil
    • 10.4.4 Mexico
    • 10.4.5 Turkey
    • 10.4.6 Saudi Arabia
    • 10.4.7 Israel
    • 10.4.8 GCC Countries

11 Key Players Profiles

  • 11.1 Catalent
    • 11.1.1 Catalent Company Details
    • 11.1.2 Catalent Business Overview
    • 11.1.3 Catalent Small Molecule CMO and CDMO Introduction
    • 11.1.4 Catalent Revenue in Small Molecule CMO and CDMO Business (2020-2025)
    • 11.1.5 Catalent Recent Development
  • 11.2 Thermo Fisher Scientific
    • 11.2.1 Thermo Fisher Scientific Company Details
    • 11.2.2 Thermo Fisher Scientific Business Overview
    • 11.2.3 Thermo Fisher Scientific Small Molecule CMO and CDMO Introduction
    • 11.2.4 Thermo Fisher Scientific Revenue in Small Molecule CMO and CDMO Business (2020-2025)
    • 11.2.5 Thermo Fisher Scientific Recent Development
  • 11.3 Lonza
    • 11.3.1 Lonza Company Details
    • 11.3.2 Lonza Business Overview
    • 11.3.3 Lonza Small Molecule CMO and CDMO Introduction
    • 11.3.4 Lonza Revenue in Small Molecule CMO and CDMO Business (2020-2025)
    • 11.3.5 Lonza Recent Development
  • 11.4 Siegfried
    • 11.4.1 Siegfried Company Details
    • 11.4.2 Siegfried Business Overview
    • 11.4.3 Siegfried Small Molecule CMO and CDMO Introduction
    • 11.4.4 Siegfried Revenue in Small Molecule CMO and CDMO Business (2020-2025)
    • 11.4.5 Siegfried Recent Development
  • 11.5 Recipharm
    • 11.5.1 Recipharm Company Details
    • 11.5.2 Recipharm Business Overview
    • 11.5.3 Recipharm Small Molecule CMO and CDMO Introduction
    • 11.5.4 Recipharm Revenue in Small Molecule CMO and CDMO Business (2020-2025)
    • 11.5.5 Recipharm Recent Development
  • 11.6 Boehringer Ingelheim
    • 11.6.1 Boehringer Ingelheim Company Details
    • 11.6.2 Boehringer Ingelheim Business Overview
    • 11.6.3 Boehringer Ingelheim Small Molecule CMO and CDMO Introduction
    • 11.6.4 Boehringer Ingelheim Revenue in Small Molecule CMO and CDMO Business (2020-2025)
    • 11.6.5 Boehringer Ingelheim Recent Development
  • 11.7 WuXi AppTech
    • 11.7.1 WuXi AppTech Company Details
    • 11.7.2 WuXi AppTech Business Overview
    • 11.7.3 WuXi AppTech Small Molecule CMO and CDMO Introduction
    • 11.7.4 WuXi AppTech Revenue in Small Molecule CMO and CDMO Business (2020-2025)
    • 11.7.5 WuXi AppTech Recent Development
  • 11.8 WuXi Biologics
    • 11.8.1 WuXi Biologics Company Details
    • 11.8.2 WuXi Biologics Business Overview
    • 11.8.3 WuXi Biologics Small Molecule CMO and CDMO Introduction
    • 11.8.4 WuXi Biologics Revenue in Small Molecule CMO and CDMO Business (2020-2025)
    • 11.8.5 WuXi Biologics Recent Development
  • 11.9 Fareva
    • 11.9.1 Fareva Company Details
    • 11.9.2 Fareva Business Overview
    • 11.9.3 Fareva Small Molecule CMO and CDMO Introduction
    • 11.9.4 Fareva Revenue in Small Molecule CMO and CDMO Business (2020-2025)
    • 11.9.5 Fareva Recent Development
  • 11.10 Samsung Biologics
    • 11.10.1 Samsung Biologics Company Details
    • 11.10.2 Samsung Biologics Business Overview
    • 11.10.3 Samsung Biologics Small Molecule CMO and CDMO Introduction
    • 11.10.4 Samsung Biologics Revenue in Small Molecule CMO and CDMO Business (2020-2025)
    • 11.10.5 Samsung Biologics Recent Development
  • 11.11 Aenova
    • 11.11.1 Aenova Company Details
    • 11.11.2 Aenova Business Overview
    • 11.11.3 Aenova Small Molecule CMO and CDMO Introduction
    • 11.11.4 Aenova Revenue in Small Molecule CMO and CDMO Business (2020-2025)
    • 11.11.5 Aenova Recent Development
  • 11.12 Delpharm
    • 11.12.1 Delpharm Company Details
    • 11.12.2 Delpharm Business Overview
    • 11.12.3 Delpharm Small Molecule CMO and CDMO Introduction
    • 11.12.4 Delpharm Revenue in Small Molecule CMO and CDMO Business (2020-2025)
    • 11.12.5 Delpharm Recent Development
  • 11.13 Strides Pharma
    • 11.13.1 Strides Pharma Company Details
    • 11.13.2 Strides Pharma Business Overview
    • 11.13.3 Strides Pharma Small Molecule CMO and CDMO Introduction
    • 11.13.4 Strides Pharma Revenue in Small Molecule CMO and CDMO Business (2020-2025)
    • 11.13.5 Strides Pharma Recent Development
  • 11.14 Piramal
    • 11.14.1 Piramal Company Details
    • 11.14.2 Piramal Business Overview
    • 11.14.3 Piramal Small Molecule CMO and CDMO Introduction
    • 11.14.4 Piramal Revenue in Small Molecule CMO and CDMO Business (2020-2025)
    • 11.14.5 Piramal Recent Development
  • 11.15 Famar
    • 11.15.1 Famar Company Details
    • 11.15.2 Famar Business Overview
    • 11.15.3 Famar Small Molecule CMO and CDMO Introduction
    • 11.15.4 Famar Revenue in Small Molecule CMO and CDMO Business (2020-2025)
    • 11.15.5 Famar Recent Development
  • 11.16 Curia
    • 11.16.1 Curia Company Details
    • 11.16.2 Curia Business Overview
    • 11.16.3 Curia Small Molecule CMO and CDMO Introduction
    • 11.16.4 Curia Revenue in Small Molecule CMO and CDMO Business (2020-2025)
    • 11.16.5 Curia Recent Development
  • 11.17 Jubilant
    • 11.17.1 Jubilant Company Details
    • 11.17.2 Jubilant Business Overview
    • 11.17.3 Jubilant Small Molecule CMO and CDMO Introduction
    • 11.17.4 Jubilant Revenue in Small Molecule CMO and CDMO Business (2020-2025)
    • 11.17.5 Jubilant Recent Development
  • 11.18 Vetter
    • 11.18.1 Vetter Company Details
    • 11.18.2 Vetter Business Overview
    • 11.18.3 Vetter Small Molecule CMO and CDMO Introduction
    • 11.18.4 Vetter Revenue in Small Molecule CMO and CDMO Business (2020-2025)
    • 11.18.5 Vetter Recent Development
  • 11.19 AGC Pharma Chemicals
    • 11.19.1 AGC Pharma Chemicals Company Details
    • 11.19.2 AGC Pharma Chemicals Business Overview
    • 11.19.3 AGC Pharma Chemicals Small Molecule CMO and CDMO Introduction
    • 11.19.4 AGC Pharma Chemicals Revenue in Small Molecule CMO and CDMO Business (2020-2025)
    • 11.19.5 AGC Pharma Chemicals Recent Development
  • 11.20 Asymchem
    • 11.20.1 Asymchem Company Details
    • 11.20.2 Asymchem Business Overview
    • 11.20.3 Asymchem Small Molecule CMO and CDMO Introduction
    • 11.20.4 Asymchem Revenue in Small Molecule CMO and CDMO Business (2020-2025)
    • 11.20.5 Asymchem Recent Development
  • 11.21 Porton
    • 11.21.1 Porton Company Details
    • 11.21.2 Porton Business Overview
    • 11.21.3 Porton Small Molecule CMO and CDMO Introduction
    • 11.21.4 Porton Revenue in Small Molecule CMO and CDMO Business (2020-2025)
    • 11.21.5 Porton Recent Development
  • 11.22 Eurofins
    • 11.22.1 Eurofins Company Details
    • 11.22.2 Eurofins Business Overview
    • 11.22.3 Eurofins Small Molecule CMO and CDMO Introduction
    • 11.22.4 Eurofins Revenue in Small Molecule CMO and CDMO Business (2020-2025)
    • 11.22.5 Eurofins Recent Development
  • 11.23 Ascendia Pharmaceuticals
    • 11.23.1 Ascendia Pharmaceuticals Company Details
    • 11.23.2 Ascendia Pharmaceuticals Business Overview
    • 11.23.3 Ascendia Pharmaceuticals Small Molecule CMO and CDMO Introduction
    • 11.23.4 Ascendia Pharmaceuticals Revenue in Small Molecule CMO and CDMO Business (2020-2025)
    • 11.23.5 Ascendia Pharmaceuticals Recent Development
  • 11.24 Ardena
    • 11.24.1 Ardena Company Details
    • 11.24.2 Ardena Business Overview
    • 11.24.3 Ardena Small Molecule CMO and CDMO Introduction
    • 11.24.4 Ardena Revenue in Small Molecule CMO and CDMO Business (2020-2025)
    • 11.24.5 Ardena Recent Development
  • 11.25 CPL
    • 11.25.1 CPL Company Details
    • 11.25.2 CPL Business Overview
    • 11.25.3 CPL Small Molecule CMO and CDMO Introduction
    • 11.25.4 CPL Revenue in Small Molecule CMO and CDMO Business (2020-2025)
    • 11.25.5 CPL Recent Development
  • 11.26 UPM Pharmaceuticals
    • 11.26.1 UPM Pharmaceuticals Company Details
    • 11.26.2 UPM Pharmaceuticals Business Overview
    • 11.26.3 UPM Pharmaceuticals Small Molecule CMO and CDMO Introduction
    • 11.26.4 UPM Pharmaceuticals Revenue in Small Molecule CMO and CDMO Business (2020-2025)
    • 11.26.5 UPM Pharmaceuticals Recent Development
  • 11.27 FUJIFILM Diosynth Biotechnologies
    • 11.27.1 FUJIFILM Diosynth Biotechnologies Company Details
    • 11.27.2 FUJIFILM Diosynth Biotechnologies Business Overview
    • 11.27.3 FUJIFILM Diosynth Biotechnologies Small Molecule CMO and CDMO Introduction
    • 11.27.4 FUJIFILM Diosynth Biotechnologies Revenue in Small Molecule CMO and CDMO Business (2020-2025)
    • 11.27.5 FUJIFILM Diosynth Biotechnologies Recent Development
  • 11.28 Groupe Parima
    • 11.28.1 Groupe Parima Company Details
    • 11.28.2 Groupe Parima Business Overview
    • 11.28.3 Groupe Parima Small Molecule CMO and CDMO Introduction
    • 11.28.4 Groupe Parima Revenue in Small Molecule CMO and CDMO Business (2020-2025)
    • 11.28.5 Groupe Parima Recent Development
  • 11.29 TBD Pharmatech
    • 11.29.1 TBD Pharmatech Company Details
    • 11.29.2 TBD Pharmatech Business Overview
    • 11.29.3 TBD Pharmatech Small Molecule CMO and CDMO Introduction
    • 11.29.4 TBD Pharmatech Revenue in Small Molecule CMO and CDMO Business (2020-2025)
    • 11.29.5 TBD Pharmatech Recent Development
  • 11.30 Avid Bioservices
    • 11.30.1 Avid Bioservices Company Details
    • 11.30.2 Avid Bioservices Business Overview
    • 11.30.3 Avid Bioservices Small Molecule CMO and CDMO Introduction
    • 11.30.4 Avid Bioservices Revenue in Small Molecule CMO and CDMO Business (2020-2025)
    • 11.30.5 Avid Bioservices Recent Development
  • 11.31 NextPharma
    • 11.31.1 NextPharma Company Details
    • 11.31.2 NextPharma Business Overview
    • 11.31.3 NextPharma Small Molecule CMO and CDMO Introduction
    • 11.31.4 NextPharma Revenue in Small Molecule CMO and CDMO Business (2020-2025)
    • 11.31.5 NextPharma Recent Development
  • 11.32 Alcami
    • 11.32.1 Alcami Company Details
    • 11.32.2 Alcami Business Overview
    • 11.32.3 Alcami Small Molecule CMO and CDMO Introduction
    • 11.32.4 Alcami Revenue in Small Molecule CMO and CDMO Business (2020-2025)
    • 11.32.5 Alcami Recent Development
  • 11.33 Societal CDMO
    • 11.33.1 Societal CDMO Company Details
    • 11.33.2 Societal CDMO Business Overview
    • 11.33.3 Societal CDMO Small Molecule CMO and CDMO Introduction
    • 11.33.4 Societal CDMO Revenue in Small Molecule CMO and CDMO Business (2020-2025)
    • 11.33.5 Societal CDMO Recent Development
  • 11.34 MedPharm
    • 11.34.1 MedPharm Company Details
    • 11.34.2 MedPharm Business Overview
    • 11.34.3 MedPharm Small Molecule CMO and CDMO Introduction
    • 11.34.4 MedPharm Revenue in Small Molecule CMO and CDMO Business (2020-2025)
    • 11.34.5 MedPharm Recent Development
  • 11.35 Euroapi
    • 11.35.1 Euroapi Company Details
    • 11.35.2 Euroapi Business Overview
    • 11.35.3 Euroapi Small Molecule CMO and CDMO Introduction
    • 11.35.4 Euroapi Revenue in Small Molecule CMO and CDMO Business (2020-2025)
    • 11.35.5 Euroapi Recent Development
  • 11.36 BioVectra
    • 11.36.1 BioVectra Company Details
    • 11.36.2 BioVectra Business Overview
    • 11.36.3 BioVectra Small Molecule CMO and CDMO Introduction
    • 11.36.4 BioVectra Revenue in Small Molecule CMO and CDMO Business (2020-2025)
    • 11.36.5 BioVectra Recent Development
  • 11.37 Pfizer CentreOne
    • 11.37.1 Pfizer CentreOne Company Details
    • 11.37.2 Pfizer CentreOne Business Overview
    • 11.37.3 Pfizer CentreOne Small Molecule CMO and CDMO Introduction
    • 11.37.4 Pfizer CentreOne Revenue in Small Molecule CMO and CDMO Business (2020-2025)
    • 11.37.5 Pfizer CentreOne Recent Development
  • 11.38 Fermion
    • 11.38.1 Fermion Company Details
    • 11.38.2 Fermion Business Overview
    • 11.38.3 Fermion Small Molecule CMO and CDMO Introduction
    • 11.38.4 Fermion Revenue in Small Molecule CMO and CDMO Business (2020-2025)
    • 11.38.5 Fermion Recent Development
  • 11.39 Lundbeck
    • 11.39.1 Lundbeck Company Details
    • 11.39.2 Lundbeck Business Overview
    • 11.39.3 Lundbeck Small Molecule CMO and CDMO Introduction
    • 11.39.4 Lundbeck Revenue in Small Molecule CMO and CDMO Business (2020-2025)
    • 11.39.5 Lundbeck Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

  • 13.1 Research Methodology
    • 13.1.1 Methodology/Research Approach
      • 13.1.1.1 Research Programs/Design
      • 13.1.1.2 Market Size Estimation
      • 13.1.1.3 Market Breakdown and Data Triangulation
    • 13.1.2 Data Source
      • 13.1.2.1 Secondary Sources
      • 13.1.2.2 Primary Sources
  • 13.2 Author Details
  • 13.3 Disclaimer

TABLE OF CONTENTS

1 Report Overview

  • 1.1 Study Scope
  • 1.2 Market Analysis by Type
    • 1.2.1 Global Small Molecule CMO and CDMO Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
    • 1.2.2 Molecular Drug Intermediates
    • 1.2.3 API
    • 1.2.4 Prepared Products
  • 1.3 Market by Application
    • 1.3.1 Global Small Molecule CMO and CDMO Market Share by Application: 2020 VS 2024 VS 2031
    • 1.3.2 Clinical
    • 1.3.3 Commercial
  • 1.4 Assumptions and Limitations
  • 1.5 Study Objectives
  • 1.6 Years Considered

2 Global Growth Trends

  • 2.1 Global Small Molecule CMO and CDMO Market Perspective (2020-2031)
  • 2.2 Global Small Molecule CMO and CDMO Growth Trends by Region
    • 2.2.1 Global Small Molecule CMO and CDMO Market Size by Region: 2020 VS 2024 VS 2031
    • 2.2.2 Small Molecule CMO and CDMO Market Size by Region (2020-2031)
  • 2.3 Small Molecule CMO and CDMO Market Dynamics
    • 2.3.1 Small Molecule CMO and CDMO Industry Trends
    • 2.3.2 Small Molecule CMO and CDMO Market Drivers
    • 2.3.3 Small Molecule CMO and CDMO Market Challenges
    • 2.3.4 Small Molecule CMO and CDMO Market Restraints

3 Competition Landscape by Key Players

  • 3.1 Global Revenue Small Molecule CMO and CDMO by Players
    • 3.1.1 Global Small Molecule CMO and CDMO Revenue by Players (2020-2025)
    • 3.1.2 Global Small Molecule CMO and CDMO Revenue Market Share by Players (2020-2025)
  • 3.2 Global Small Molecule CMO and CDMO Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
  • 3.3 Global Key Players of Small Molecule CMO and CDMO, Ranking by Revenue, 2023 VS 2024 VS 2025
  • 3.4 Global Market Concentration Ratio
    • 3.4.1 Global Small Molecule CMO and CDMO Market Concentration Ratio (CR5 and HHI)
    • 3.4.2 Global Top 10 and Top 5 Companies by Small Molecule CMO and CDMO Revenue in 2024
  • 3.5 Global Key Players of Small Molecule CMO and CDMO Head office and Area Served
  • 3.6 Global Key Players of Small Molecule CMO and CDMO, Product and Application
  • 3.7 Global Key Players of Small Molecule CMO and CDMO, Date of Enter into This Industry
  • 3.8 Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Type

  • 4.1 Global Small Molecule CMO and CDMO Historic Market Size by Type (2020-2025)
  • 4.2 Global Small Molecule CMO and CDMO Forecasted Market Size by Type (2026-2031)

5 Breakdown Data by Application

  • 5.1 Global Small Molecule CMO and CDMO Historic Market Size by Application (2020-2025)
  • 5.2 Global Small Molecule CMO and CDMO Forecasted Market Size by Application (2026-2031)

6 North America

  • 6.1 North America Small Molecule CMO and CDMO Market Size (2020-2031)
  • 6.2 North America Market Size by Type
    • 6.2.1 North America Small Molecule CMO and CDMO Market Size by Type (2020-2031)
    • 6.2.2 North America Small Molecule CMO and CDMO Market Share by Type (2020-2031)
  • 6.3 North America Market Size by Application
    • 6.3.1 North America Small Molecule CMO and CDMO Market Size by Application (2020-2031)
    • 6.3.2 North America Small Molecule CMO and CDMO Market Share by Application (2020-2031)
  • 6.4 North America Market Size by Country
    • 6.4.1 North America Small Molecule CMO and CDMO Market Size by Country: 2020 VS 2024 VS 2031
    • 6.4.2 North America Small Molecule CMO and CDMO Market Size by Country (2020-2031)
    • 6.4.3 United States
    • 6.4.4 Canada

7 Europe

  • 7.1 Europe Small Molecule CMO and CDMO Market Size (2020-2031)
  • 7.2 Europe Market Size by Type
    • 7.2.1 Europe Small Molecule CMO and CDMO Market Size by Type (2020-2031)
    • 7.2.2 Europe Small Molecule CMO and CDMO Market Share by Type (2020-2031)
  • 7.3 Europe Market Size by Application
    • 7.3.1 Europe Small Molecule CMO and CDMO Market Size by Application (2020-2031)
    • 7.3.2 Europe Small Molecule CMO and CDMO Market Share by Application (2020-2031)
  • 7.4 Europe Market Size by Country
    • 7.4.1 Europe Small Molecule CMO and CDMO Market Size by Country: 2020 VS 2024 VS 2031
    • 7.4.2 Europe Small Molecule CMO and CDMO Market Size by Country (2020-2025)
    • 7.4.3 Germany
    • 7.4.4 France
    • 7.4.5 U.K.
    • 7.4.6 Italy
    • 7.4.7 Russia
    • 7.4.8 Nordic Countries

8 China

  • 8.1 China Small Molecule CMO and CDMO Market Size (2020-2031)
  • 8.2 China Market Size by Type
    • 8.2.1 China Small Molecule CMO and CDMO Market Size by Type (2020-2031)
    • 8.2.2 China Small Molecule CMO and CDMO Market Share by Type (2020-2031)
  • 8.3 China Market Size by Application
    • 8.3.1 China Small Molecule CMO and CDMO Market Size by Application (2020-2031)
    • 8.3.2 China Small Molecule CMO and CDMO Market Share by Application (2020-2031)

9 Asia (excluding China)

  • 9.1 Asia Small Molecule CMO and CDMO Market Size (2020-2031)
  • 9.2 Asia Market Size by Type
    • 9.2.1 Asia Small Molecule CMO and CDMO Market Size by Type (2020-2031)
    • 9.2.2 Asia Small Molecule CMO and CDMO Market Share by Type (2020-2031)
  • 9.3 Asia Market Size by Application
    • 9.3.1 Asia Small Molecule CMO and CDMO Market Size by Application (2020-2031)
    • 9.3.2 Asia Small Molecule CMO and CDMO Market Share by Application (2020-2031)
  • 9.4 Asia Market Size by Region
    • 9.4.1 Asia Small Molecule CMO and CDMO Market Size by Region: 2020 VS 2024 VS 2031
    • 9.4.2 Asia Small Molecule CMO and CDMO Market Size by Region (2020-2031)
    • 9.4.3 Japan
    • 9.4.4 South Korea
    • 9.4.5 China Taiwan
    • 9.4.6 Southeast Asia
    • 9.4.7 India
    • 9.4.8 Australia

10 Middle East, Africa, and Latin America

  • 10.1 Middle East, Africa, and Latin America Small Molecule CMO and CDMO Market Size (2020-2031)
  • 10.2 Middle East, Africa, and Latin America Market Size by Type
    • 10.2.1 Middle East, Africa, and Latin America Small Molecule CMO and CDMO Market Size by Type (2020-2031)
    • 10.2.2 Middle East, Africa, and Latin America Small Molecule CMO and CDMO Market Share by Type (2020-2031)
  • 10.3 Middle East, Africa, and Latin America Market Size by Application
    • 10.3.1 Middle East, Africa, and Latin America Small Molecule CMO and CDMO Market Size by Application (2020-2031)
    • 10.3.2 Middle East, Africa, and Latin America Market Share by Application (2020-2031)
  • 10.4 Middle East, Africa, and Latin America Market Size by Country
    • 10.4.1 Middle East, Africa, and Latin America Small Molecule CMO and CDMO Market Size by Country: 2020 VS 2024 VS 2031
    • 10.4.2 Middle East, Africa, and Latin America Small Molecule CMO and CDMO Market Size by Country (2020-2031)
    • 10.4.3 Brazil
    • 10.4.4 Mexico
    • 10.4.5 Turkey
    • 10.4.6 Saudi Arabia
    • 10.4.7 Israel
    • 10.4.8 GCC Countries

11 Key Players Profiles

  • 11.1 Catalent
    • 11.1.1 Catalent Company Details
    • 11.1.2 Catalent Business Overview
    • 11.1.3 Catalent Small Molecule CMO and CDMO Introduction
    • 11.1.4 Catalent Revenue in Small Molecule CMO and CDMO Business (2020-2025)
    • 11.1.5 Catalent Recent Development
  • 11.2 Thermo Fisher Scientific
    • 11.2.1 Thermo Fisher Scientific Company Details
    • 11.2.2 Thermo Fisher Scientific Business Overview
    • 11.2.3 Thermo Fisher Scientific Small Molecule CMO and CDMO Introduction
    • 11.2.4 Thermo Fisher Scientific Revenue in Small Molecule CMO and CDMO Business (2020-2025)
    • 11.2.5 Thermo Fisher Scientific Recent Development
  • 11.3 Lonza
    • 11.3.1 Lonza Company Details
    • 11.3.2 Lonza Business Overview
    • 11.3.3 Lonza Small Molecule CMO and CDMO Introduction
    • 11.3.4 Lonza Revenue in Small Molecule CMO and CDMO Business (2020-2025)
    • 11.3.5 Lonza Recent Development
  • 11.4 Siegfried
    • 11.4.1 Siegfried Company Details
    • 11.4.2 Siegfried Business Overview
    • 11.4.3 Siegfried Small Molecule CMO and CDMO Introduction
    • 11.4.4 Siegfried Revenue in Small Molecule CMO and CDMO Business (2020-2025)
    • 11.4.5 Siegfried Recent Development
  • 11.5 Recipharm
    • 11.5.1 Recipharm Company Details
    • 11.5.2 Recipharm Business Overview
    • 11.5.3 Recipharm Small Molecule CMO and CDMO Introduction
    • 11.5.4 Recipharm Revenue in Small Molecule CMO and CDMO Business (2020-2025)
    • 11.5.5 Recipharm Recent Development
  • 11.6 Boehringer Ingelheim
    • 11.6.1 Boehringer Ingelheim Company Details
    • 11.6.2 Boehringer Ingelheim Business Overview
    • 11.6.3 Boehringer Ingelheim Small Molecule CMO and CDMO Introduction
    • 11.6.4 Boehringer Ingelheim Revenue in Small Molecule CMO and CDMO Business (2020-2025)
    • 11.6.5 Boehringer Ingelheim Recent Development
  • 11.7 WuXi AppTech
    • 11.7.1 WuXi AppTech Company Details
    • 11.7.2 WuXi AppTech Business Overview
    • 11.7.3 WuXi AppTech Small Molecule CMO and CDMO Introduction
    • 11.7.4 WuXi AppTech Revenue in Small Molecule CMO and CDMO Business (2020-2025)
    • 11.7.5 WuXi AppTech Recent Development
  • 11.8 WuXi Biologics
    • 11.8.1 WuXi Biologics Company Details
    • 11.8.2 WuXi Biologics Business Overview
    • 11.8.3 WuXi Biologics Small Molecule CMO and CDMO Introduction
    • 11.8.4 WuXi Biologics Revenue in Small Molecule CMO and CDMO Business (2020-2025)
    • 11.8.5 WuXi Biologics Recent Development
  • 11.9 Fareva
    • 11.9.1 Fareva Company Details
    • 11.9.2 Fareva Business Overview
    • 11.9.3 Fareva Small Molecule CMO and CDMO Introduction
    • 11.9.4 Fareva Revenue in Small Molecule CMO and CDMO Business (2020-2025)
    • 11.9.5 Fareva Recent Development
  • 11.10 Samsung Biologics
    • 11.10.1 Samsung Biologics Company Details
    • 11.10.2 Samsung Biologics Business Overview
    • 11.10.3 Samsung Biologics Small Molecule CMO and CDMO Introduction
    • 11.10.4 Samsung Biologics Revenue in Small Molecule CMO and CDMO Business (2020-2025)
    • 11.10.5 Samsung Biologics Recent Development
  • 11.11 Aenova
    • 11.11.1 Aenova Company Details
    • 11.11.2 Aenova Business Overview
    • 11.11.3 Aenova Small Molecule CMO and CDMO Introduction
    • 11.11.4 Aenova Revenue in Small Molecule CMO and CDMO Business (2020-2025)
    • 11.11.5 Aenova Recent Development
  • 11.12 Delpharm
    • 11.12.1 Delpharm Company Details
    • 11.12.2 Delpharm Business Overview
    • 11.12.3 Delpharm Small Molecule CMO and CDMO Introduction
    • 11.12.4 Delpharm Revenue in Small Molecule CMO and CDMO Business (2020-2025)
    • 11.12.5 Delpharm Recent Development
  • 11.13 Strides Pharma
    • 11.13.1 Strides Pharma Company Details
    • 11.13.2 Strides Pharma Business Overview
    • 11.13.3 Strides Pharma Small Molecule CMO and CDMO Introduction
    • 11.13.4 Strides Pharma Revenue in Small Molecule CMO and CDMO Business (2020-2025)
    • 11.13.5 Strides Pharma Recent Development
  • 11.14 Piramal
    • 11.14.1 Piramal Company Details
    • 11.14.2 Piramal Business Overview
    • 11.14.3 Piramal Small Molecule CMO and CDMO Introduction
    • 11.14.4 Piramal Revenue in Small Molecule CMO and CDMO Business (2020-2025)
    • 11.14.5 Piramal Recent Development
  • 11.15 Famar
    • 11.15.1 Famar Company Details
    • 11.15.2 Famar Business Overview
    • 11.15.3 Famar Small Molecule CMO and CDMO Introduction
    • 11.15.4 Famar Revenue in Small Molecule CMO and CDMO Business (2020-2025)
    • 11.15.5 Famar Recent Development
  • 11.16 Curia
    • 11.16.1 Curia Company Details
    • 11.16.2 Curia Business Overview
    • 11.16.3 Curia Small Molecule CMO and CDMO Introduction
    • 11.16.4 Curia Revenue in Small Molecule CMO and CDMO Business (2020-2025)
    • 11.16.5 Curia Recent Development
  • 11.17 Jubilant
    • 11.17.1 Jubilant Company Details
    • 11.17.2 Jubilant Business Overview
    • 11.17.3 Jubilant Small Molecule CMO and CDMO Introduction
    • 11.17.4 Jubilant Revenue in Small Molecule CMO and CDMO Business (2020-2025)
    • 11.17.5 Jubilant Recent Development
  • 11.18 Vetter
    • 11.18.1 Vetter Company Details
    • 11.18.2 Vetter Business Overview
    • 11.18.3 Vetter Small Molecule CMO and CDMO Introduction
    • 11.18.4 Vetter Revenue in Small Molecule CMO and CDMO Business (2020-2025)
    • 11.18.5 Vetter Recent Development
  • 11.19 AGC Pharma Chemicals
    • 11.19.1 AGC Pharma Chemicals Company Details
    • 11.19.2 AGC Pharma Chemicals Business Overview
    • 11.19.3 AGC Pharma Chemicals Small Molecule CMO and CDMO Introduction
    • 11.19.4 AGC Pharma Chemicals Revenue in Small Molecule CMO and CDMO Business (2020-2025)
    • 11.19.5 AGC Pharma Chemicals Recent Development
  • 11.20 Asymchem
    • 11.20.1 Asymchem Company Details
    • 11.20.2 Asymchem Business Overview
    • 11.20.3 Asymchem Small Molecule CMO and CDMO Introduction
    • 11.20.4 Asymchem Revenue in Small Molecule CMO and CDMO Business (2020-2025)
    • 11.20.5 Asymchem Recent Development
  • 11.21 Porton
    • 11.21.1 Porton Company Details
    • 11.21.2 Porton Business Overview
    • 11.21.3 Porton Small Molecule CMO and CDMO Introduction
    • 11.21.4 Porton Revenue in Small Molecule CMO and CDMO Business (2020-2025)
    • 11.21.5 Porton Recent Development
  • 11.22 Eurofins
    • 11.22.1 Eurofins Company Details
    • 11.22.2 Eurofins Business Overview
    • 11.22.3 Eurofins Small Molecule CMO and CDMO Introduction
    • 11.22.4 Eurofins Revenue in Small Molecule CMO and CDMO Business (2020-2025)
    • 11.22.5 Eurofins Recent Development
  • 11.23 Ascendia Pharmaceuticals
    • 11.23.1 Ascendia Pharmaceuticals Company Details
    • 11.23.2 Ascendia Pharmaceuticals Business Overview
    • 11.23.3 Ascendia Pharmaceuticals Small Molecule CMO and CDMO Introduction
    • 11.23.4 Ascendia Pharmaceuticals Revenue in Small Molecule CMO and CDMO Business (2020-2025)
    • 11.23.5 Ascendia Pharmaceuticals Recent Development
  • 11.24 Ardena
    • 11.24.1 Ardena Company Details
    • 11.24.2 Ardena Business Overview
    • 11.24.3 Ardena Small Molecule CMO and CDMO Introduction
    • 11.24.4 Ardena Revenue in Small Molecule CMO and CDMO Business (2020-2025)
    • 11.24.5 Ardena Recent Development
  • 11.25 CPL
    • 11.25.1 CPL Company Details
    • 11.25.2 CPL Business Overview
    • 11.25.3 CPL Small Molecule CMO and CDMO Introduction
    • 11.25.4 CPL Revenue in Small Molecule CMO and CDMO Business (2020-2025)
    • 11.25.5 CPL Recent Development
  • 11.26 UPM Pharmaceuticals
    • 11.26.1 UPM Pharmaceuticals Company Details
    • 11.26.2 UPM Pharmaceuticals Business Overview
    • 11.26.3 UPM Pharmaceuticals Small Molecule CMO and CDMO Introduction
    • 11.26.4 UPM Pharmaceuticals Revenue in Small Molecule CMO and CDMO Business (2020-2025)
    • 11.26.5 UPM Pharmaceuticals Recent Development
  • 11.27 FUJIFILM Diosynth Biotechnologies
    • 11.27.1 FUJIFILM Diosynth Biotechnologies Company Details
    • 11.27.2 FUJIFILM Diosynth Biotechnologies Business Overview
    • 11.27.3 FUJIFILM Diosynth Biotechnologies Small Molecule CMO and CDMO Introduction
    • 11.27.4 FUJIFILM Diosynth Biotechnologies Revenue in Small Molecule CMO and CDMO Business (2020-2025)
    • 11.27.5 FUJIFILM Diosynth Biotechnologies Recent Development
  • 11.28 Groupe Parima
    • 11.28.1 Groupe Parima Company Details
    • 11.28.2 Groupe Parima Business Overview
    • 11.28.3 Groupe Parima Small Molecule CMO and CDMO Introduction
    • 11.28.4 Groupe Parima Revenue in Small Molecule CMO and CDMO Business (2020-2025)
    • 11.28.5 Groupe Parima Recent Development
  • 11.29 TBD Pharmatech
    • 11.29.1 TBD Pharmatech Company Details
    • 11.29.2 TBD Pharmatech Business Overview
    • 11.29.3 TBD Pharmatech Small Molecule CMO and CDMO Introduction
    • 11.29.4 TBD Pharmatech Revenue in Small Molecule CMO and CDMO Business (2020-2025)
    • 11.29.5 TBD Pharmatech Recent Development
  • 11.30 Avid Bioservices
    • 11.30.1 Avid Bioservices Company Details
    • 11.30.2 Avid Bioservices Business Overview
    • 11.30.3 Avid Bioservices Small Molecule CMO and CDMO Introduction
    • 11.30.4 Avid Bioservices Revenue in Small Molecule CMO and CDMO Business (2020-2025)
    • 11.30.5 Avid Bioservices Recent Development
  • 11.31 NextPharma
    • 11.31.1 NextPharma Company Details
    • 11.31.2 NextPharma Business Overview
    • 11.31.3 NextPharma Small Molecule CMO and CDMO Introduction
    • 11.31.4 NextPharma Revenue in Small Molecule CMO and CDMO Business (2020-2025)
    • 11.31.5 NextPharma Recent Development
  • 11.32 Alcami
    • 11.32.1 Alcami Company Details
    • 11.32.2 Alcami Business Overview
    • 11.32.3 Alcami Small Molecule CMO and CDMO Introduction
    • 11.32.4 Alcami Revenue in Small Molecule CMO and CDMO Business (2020-2025)
    • 11.32.5 Alcami Recent Development
  • 11.33 Societal CDMO
    • 11.33.1 Societal CDMO Company Details
    • 11.33.2 Societal CDMO Business Overview
    • 11.33.3 Societal CDMO Small Molecule CMO and CDMO Introduction
    • 11.33.4 Societal CDMO Revenue in Small Molecule CMO and CDMO Business (2020-2025)
    • 11.33.5 Societal CDMO Recent Development
  • 11.34 MedPharm
    • 11.34.1 MedPharm Company Details
    • 11.34.2 MedPharm Business Overview
    • 11.34.3 MedPharm Small Molecule CMO and CDMO Introduction
    • 11.34.4 MedPharm Revenue in Small Molecule CMO and CDMO Business (2020-2025)
    • 11.34.5 MedPharm Recent Development
  • 11.35 Euroapi
    • 11.35.1 Euroapi Company Details
    • 11.35.2 Euroapi Business Overview
    • 11.35.3 Euroapi Small Molecule CMO and CDMO Introduction
    • 11.35.4 Euroapi Revenue in Small Molecule CMO and CDMO Business (2020-2025)
    • 11.35.5 Euroapi Recent Development
  • 11.36 BioVectra
    • 11.36.1 BioVectra Company Details
    • 11.36.2 BioVectra Business Overview
    • 11.36.3 BioVectra Small Molecule CMO and CDMO Introduction
    • 11.36.4 BioVectra Revenue in Small Molecule CMO and CDMO Business (2020-2025)
    • 11.36.5 BioVectra Recent Development
  • 11.37 Pfizer CentreOne
    • 11.37.1 Pfizer CentreOne Company Details
    • 11.37.2 Pfizer CentreOne Business Overview
    • 11.37.3 Pfizer CentreOne Small Molecule CMO and CDMO Introduction
    • 11.37.4 Pfizer CentreOne Revenue in Small Molecule CMO and CDMO Business (2020-2025)
    • 11.37.5 Pfizer CentreOne Recent Development
  • 11.38 Fermion
    • 11.38.1 Fermion Company Details
    • 11.38.2 Fermion Business Overview
    • 11.38.3 Fermion Small Molecule CMO and CDMO Introduction
    • 11.38.4 Fermion Revenue in Small Molecule CMO and CDMO Business (2020-2025)
    • 11.38.5 Fermion Recent Development
  • 11.39 Lundbeck
    • 11.39.1 Lundbeck Company Details
    • 11.39.2 Lundbeck Business Overview
    • 11.39.3 Lundbeck Small Molecule CMO and CDMO Introduction
    • 11.39.4 Lundbeck Revenue in Small Molecule CMO and CDMO Business (2020-2025)
    • 11.39.5 Lundbeck Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

  • 13.1 Research Methodology
    • 13.1.1 Methodology/Research Approach
      • 13.1.1.1 Research Programs/Design
      • 13.1.1.2 Market Size Estimation
      • 13.1.1.3 Market Breakdown and Data Triangulation
    • 13.1.2 Data Source
      • 13.1.2.1 Secondary Sources
      • 13.1.2.2 Primary Sources
  • 13.2 Author Details
  • 13.3 Disclaimer

List of Tables

Table 1. Global Small Molecule CMO and CDMO Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031

Table 2. Key Players of Molecular Drug Intermediates

Table 3. Key Players of API

Table 4. Key Players of Prepared Products

Table 5. Global Small Molecule CMO and CDMO Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031

Table 6. Global Small Molecule CMO and CDMO Market Size Growth Rate (CAGR) by Region (US$ Million): 2020 VS 2024 VS 2031

Table 7. Global Market Size by Region (2020-2031) & (US$ Million)

Table 8. Global Small Molecule CMO and CDMO Market Share by Region (2020-2031)

Table 9. Market Trends

Table 10. Market Drivers

Table 11. Market Challenges

Table 12. Market Restraints

Table 13. Global Small Molecule CMO and CDMO Revenue by Players (2020-2025) & (US$ Million)

Table 14. Global Small Molecule CMO and CDMO Market Share by Players (2020-2025)

Table 15. Global Top Small Molecule CMO and CDMO Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Small Molecule CMO and CDMO as of 2024)

Table 16. Global Small Molecule CMO and CDMO Industry Ranking 2023 VS 2024

Table 17. Global 5 Largest Players Market Share by Small Molecule CMO and CDMO Revenue (CR5 and HHI) & (2020-2025)

Table 18. Global Key Players of Small Molecule CMO and CDMO, Headquarters and Area Served

Table 19. Global Key Players of Small Molecule CMO and CDMO, Product and Application

Table 20. Global Key Players of Small Molecule CMO and CDMO, Date of Enter into This Industry

Table 21. Mergers & Acquisitions, Expansion Plans

Table 22. Global Market Size by Type (2020-2025) & (US$ Million)

Table 23. Global Small Molecule CMO and CDMO Revenue Market Share by Type (2020-2025)

Table 24. Global Forecasted Market Size by Type (2026-2031) & (US$ Million)

Table 25. Global Small Molecule CMO and CDMO Revenue Market Share by Type (2026-2031)

Table 26. Global Market Size by Application (2020-2025) & (US$ Million)

Table 27. Global Small Molecule CMO and CDMO Revenue Market Share by Application (2020-2025)

Table 28. Global Forecasted Market Size by Application (2026-2031) & (US$ Million)

Table 29. Global Small Molecule CMO and CDMO Revenue Market Share by Application (2026-2031)

Table 30. North America Market Size by Type (2020-2031) & (US$ Million)

Table 31. North America Market Size by Application (2020-2031) & (US$ Million)

Table 32. North America Small Molecule CMO and CDMO Growth Rate (CAGR) by Country (US$ Million): 2020 VS 2024 VS 2031

Table 33. North America Market Size by Country (2020-2031) & (US$ Million)

Table 34. Europe Market Size by Type (2020-2031) & (US$ Million)

Table 35. Europe Market Size by Application (2020-2031) & (US$ Million)

Table 36. Europe Small Molecule CMO and CDMO Growth Rate (CAGR) by Country (US$ Million): 2020 VS 2024 VS 2031

Table 37. Europe Market Size by Country (2020-2025) & (US$ Million)

Table 38. China Market Size by Type (2020-2031) & (US$ Million)

Table 39. China Market Size by Application (2020-2031) & (US$ Million)

Table 40. Asia Market Size by Type (2020-2031) & (US$ Million)

Table 41. Asia Market Size by Application (2020-2025) & (US$ Million)

Table 42. Asia Small Molecule CMO and CDMO Growth Rate (CAGR) by Region (US$ Million): 2020 VS 2024 VS 2031

Table 43. Asia Market Size by Region (2020-2031) & (US$ Million)

Table 44. Middle East, Africa, and Latin America Market Size by Type (2020-2031) & (US$ Million)

Table 45. Middle East, Africa, and Latin America Market Size by Application (2020-2031) & (US$ Million)

Table 46. Middle East, Africa, and Latin America Small Molecule CMO and CDMO Growth Rate (CAGR) by Country (US$ Million): 2020 VS 2024 VS 2031

Table 47. Middle East, Africa, and Latin America Market Size by Country (2020-2031) & (US$ Million)

Table 48. Catalent Company Details

Table 49. Catalent Business Overview

Table 50. Catalent Small Molecule CMO and CDMO Product

Table 51. Catalent Revenue (2020-2025) & (US$ Million)

Table 52. Catalent Recent Development

Table 53. Thermo Fisher Scientific Company Details

Table 54. Thermo Fisher Scientific Business Overview

Table 55. Thermo Fisher Scientific Small Molecule CMO and CDMO Product

Table 56. Thermo Fisher Scientific Revenue (2020-2025) & (US$ Million)

Table 57. Thermo Fisher Scientific Recent Development

Table 58. Lonza Company Details

Table 59. Lonza Business Overview

Table 60. Lonza Small Molecule CMO and CDMO Product

Table 61. Lonza Revenue (2020-2025) & (US$ Million)

Table 62. Lonza Recent Development

Table 63. Siegfried Company Details

Table 64. Siegfried Business Overview

Table 65. Siegfried Small Molecule CMO and CDMO Product

Table 66. Siegfried Revenue (2020-2025) & (US$ Million)

Table 67. Siegfried Recent Development

Table 68. Recipharm Company Details

Table 69. Recipharm Business Overview

Table 70. Recipharm Small Molecule CMO and CDMO Product

Table 71. Recipharm Revenue (2020-2025) & (US$ Million)

Table 72. Recipharm Recent Development

Table 73. Boehringer Ingelheim Company Details

Table 74. Boehringer Ingelheim Business Overview

Table 75. Boehringer Ingelheim Small Molecule CMO and CDMO Product

Table 76. Boehringer Ingelheim Revenue (2020-2025) & (US$ Million)

Table 77. Boehringer Ingelheim Recent Development

Table 78. WuXi AppTech Company Details

Table 79. WuXi AppTech Business Overview

Table 80. WuXi AppTech Small Molecule CMO and CDMO Product

Table 81. WuXi AppTech Revenue (2020-2025) & (US$ Million)

Table 82. WuXi AppTech Recent Development

Table 83. WuXi Biologics Company Details

Table 84. WuXi Biologics Business Overview

Table 85. WuXi Biologics Small Molecule CMO and CDMO Product

Table 86. WuXi Biologics Revenue (2020-2025) & (US$ Million)

Table 87. WuXi Biologics Recent Development

Table 88. Fareva Company Details

Table 89. Fareva Business Overview

Table 90. Fareva Small Molecule CMO and CDMO Product

Table 91. Fareva Revenue (2020-2025) & (US$ Million)

Table 92. Fareva Recent Development

Table 93. Samsung Biologics Company Details

Table 94. Samsung Biologics Business Overview

Table 95. Samsung Biologics Small Molecule CMO and CDMO Product

Table 96. Samsung Biologics Revenue (2020-2025) & (US$ Million)

Table 97. Samsung Biologics Recent Development

Table 98. Aenova Company Details

Table 99. Aenova Business Overview

Table 100. Aenova Small Molecule CMO and CDMO Product

Table 101. Aenova Revenue (2020-2025) & (US$ Million)

Table 102. Aenova Recent Development

Table 103. Delpharm Company Details

Table 104. Delpharm Business Overview

Table 105. Delpharm Small Molecule CMO and CDMO Product

Table 106. Delpharm Revenue (2020-2025) & (US$ Million)

Table 107. Delpharm Recent Development

Table 108. Strides Pharma Company Details

Table 109. Strides Pharma Business Overview

Table 110. Strides Pharma Small Molecule CMO and CDMO Product

Table 111. Strides Pharma Revenue (2020-2025) & (US$ Million)

Table 112. Strides Pharma Recent Development

Table 113. Piramal Company Details

Table 114. Piramal Business Overview

Table 115. Piramal Small Molecule CMO and CDMO Product

Table 116. Piramal Revenue (2020-2025) & (US$ Million)

Table 117. Piramal Recent Development

Table 118. Famar Company Details

Table 119. Famar Business Overview

Table 120. Famar Small Molecule CMO and CDMO Product

Table 121. Famar Revenue (2020-2025) & (US$ Million)

Table 122. Famar Recent Development

Table 123. Curia Company Details

Table 124. Curia Business Overview

Table 125. Curia Small Molecule CMO and CDMO Product

Table 126. Curia Revenue (2020-2025) & (US$ Million)

Table 127. Curia Recent Development

Table 128. Jubilant Company Details

Table 129. Jubilant Business Overview

Table 130. Jubilant Small Molecule CMO and CDMO Product

Table 131. Jubilant Revenue (2020-2025) & (US$ Million)

Table 132. Jubilant Recent Development

Table 133. Vetter Company Details

Table 134. Vetter Business Overview

Table 135. Vetter Small Molecule CMO and CDMO Product

Table 136. Vetter Revenue (2020-2025) & (US$ Million)

Table 137. Vetter Recent Development

Table 138. AGC Pharma Chemicals Company Details

Table 139. AGC Pharma Chemicals Business Overview

Table 140. AGC Pharma Chemicals Small Molecule CMO and CDMO Product

Table 141. AGC Pharma Chemicals Revenue (2020-2025) & (US$ Million)

Table 142. AGC Pharma Chemicals Recent Development

Table 143. Asymchem Company Details

Table 144. Asymchem Business Overview

Table 145. Asymchem Small Molecule CMO and CDMO Product

Table 146. Asymchem Revenue (2020-2025) & (US$ Million)

Table 147. Asymchem Recent Development

Table 148. Porton Company Details

Table 149. Porton Business Overview

Table 150. Porton Small Molecule CMO and CDMO Product

Table 151. Porton Revenue (2020-2025) & (US$ Million)

Table 152. Porton Recent Development

Table 153. Eurofins Company Details

Table 154. Eurofins Business Overview

Table 155. Eurofins Small Molecule CMO and CDMO Product

Table 156. Eurofins Revenue (2020-2025) & (US$ Million)

Table 157. Eurofins Recent Development

Table 158. Ascendia Pharmaceuticals Company Details

Table 159. Ascendia Pharmaceuticals Business Overview

Table 160. Ascendia Pharmaceuticals Small Molecule CMO and CDMO Product

Table 161. Ascendia Pharmaceuticals Revenue (2020-2025) & (US$ Million)

Table 162. Ascendia Pharmaceuticals Recent Development

Table 163. Ardena Company Details

Table 164. Ardena Business Overview

Table 165. Ardena Small Molecule CMO and CDMO Product

Table 166. Ardena Revenue (2020-2025) & (US$ Million)

Table 167. Ardena Recent Development

Table 168. CPL Company Details

Table 169. CPL Business Overview

Table 170. CPL Small Molecule CMO and CDMO Product

Table 171. CPL Revenue (2020-2025) & (US$ Million)

Table 172. CPL Recent Development

Table 173. UPM Pharmaceuticals Company Details

Table 174. UPM Pharmaceuticals Business Overview

Table 175. UPM Pharmaceuticals Small Molecule CMO and CDMO Product

Table 176. UPM Pharmaceuticals Revenue (2020-2025) & (US$ Million)

Table 177. UPM Pharmaceuticals Recent Development

Table 178. FUJIFILM Diosynth Biotechnologies Company Details

Table 179. FUJIFILM Diosynth Biotechnologies Business Overview

Table 180. FUJIFILM Diosynth Biotechnologies Small Molecule CMO and CDMO Product

Table 181. FUJIFILM Diosynth Biotechnologies Revenue (2020-2025) & (US$ Million)

Table 182. FUJIFILM Diosynth Biotechnologies Recent Development

Table 183. Groupe Parima Company Details

Table 184. Groupe Parima Business Overview

Table 185. Groupe Parima Small Molecule CMO and CDMO Product

Table 186. Groupe Parima Revenue (2020-2025) & (US$ Million)

Table 187. Groupe Parima Recent Development

Table 188. TBD Pharmatech Company Details

Table 189. TBD Pharmatech Business Overview

Table 190. TBD Pharmatech Small Molecule CMO and CDMO Product

Table 191. TBD Pharmatech Revenue (2020-2025) & (US$ Million)

Table 192. TBD Pharmatech Recent Development

Table 193. Avid Bioservices Company Details

Table 194. Avid Bioservices Business Overview

Table 195. Avid Bioservices Small Molecule CMO and CDMO Product

Table 196. Avid Bioservices Revenue (2020-2025) & (US$ Million)

Table 197. Avid Bioservices Recent Development

Table 198. NextPharma Company Details

Table 199. NextPharma Business Overview

Table 200. NextPharma Small Molecule CMO and CDMO Product

Table 201. NextPharma Revenue (2020-2025) & (US$ Million)

Table 202. NextPharma Recent Development

Table 203. Alcami Company Details

Table 204. Alcami Business Overview

Table 205. Alcami Small Molecule CMO and CDMO Product

Table 206. Alcami Revenue (2020-2025) & (US$ Million)

Table 207. Alcami Recent Development

Table 208. Societal CDMO Company Details

Table 209. Societal CDMO Business Overview

Table 210. Societal CDMO Small Molecule CMO and CDMO Product

Table 211. Societal CDMO Revenue (2020-2025) & (US$ Million)

Table 212. Societal CDMO Recent Development

Table 213. MedPharm Company Details

Table 214. MedPharm Business Overview

Table 215. MedPharm Small Molecule CMO and CDMO Product

Table 216. MedPharm Revenue (2020-2025) & (US$ Million)

Table 217. MedPharm Recent Development

Table 218. Euroapi Company Details

Table 219. Euroapi Business Overview

Table 220. Euroapi Small Molecule CMO and CDMO Product

Table 221. Euroapi Revenue (2020-2025) & (US$ Million)

Table 222. Euroapi Recent Development

Table 223. BioVectra Company Details

Table 224. BioVectra Business Overview

Table 225. BioVectra Small Molecule CMO and CDMO Product

Table 226. BioVectra Revenue (2020-2025) & (US$ Million)

Table 227. BioVectra Recent Development

Table 228. Pfizer CentreOne Company Details

Table 229. Pfizer CentreOne Business Overview

Table 230. Pfizer CentreOne Small Molecule CMO and CDMO Product

Table 231. Pfizer CentreOne Revenue (2020-2025) & (US$ Million)

Table 232. Pfizer CentreOne Recent Development

Table 233. Fermion Company Details

Table 234. Fermion Business Overview

Table 235. Fermion Small Molecule CMO and CDMO Product

Table 236. Fermion Revenue (2020-2025) & (US$ Million)

Table 237. Fermion Recent Development

Table 238. Lundbeck Company Details

Table 239. Lundbeck Business Overview

Table 240. Lundbeck Small Molecule CMO and CDMO Product

Table 241. Lundbeck Revenue (2020-2025) & (US$ Million)

Table 242. Lundbeck Recent Development

Table 243. Research Programs/Design for This Report

Table 244. Key Data Information from Secondary Sources

Table 245. Key Data Information from Primary Sources

List of Figures

Figure 1. Global Small Molecule CMO and CDMO Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)

Figure 2. Global Small Molecule CMO and CDMO Market Share by Type: 2024 VS 2031

Figure 3. Molecular Drug Intermediates Features

Figure 4. API Features

Figure 5. Prepared Products Features

Figure 6. Global Small Molecule CMO and CDMO Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)

Figure 7. Global Small Molecule CMO and CDMO Market Share by Application: 2024 VS 2031

Figure 8. Clinical Case Studies

Figure 9. Commercial Case Studies

Figure 10. Small Molecule CMO and CDMO Report Years Considered

Figure 11. Global Small Molecule CMO and CDMO Market Size (US$ Million), Year-over-Year: 2020-2031

Figure 12. Global Small Molecule CMO and CDMO Market Size, (US$ Million), 2020 VS 2024 VS 2031

Figure 13. Global Small Molecule CMO and CDMO Market Share by Region: 2024 VS 2031

Figure 14. Global Small Molecule CMO and CDMO Market Share by Players in 2024

Figure 15. Global Top Small Molecule CMO and CDMO Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Small Molecule CMO and CDMO as of 2024)

Figure 16. The Top 10 and 5 Players Market Share by Small Molecule CMO and CDMO Revenue in 2024

Figure 17. North America Small Molecule CMO and CDMO Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 18. North America Small Molecule CMO and CDMO Market Share by Type (2020-2031)

Figure 19. North America Small Molecule CMO and CDMO Market Share by Application (2020-2031)

Figure 20. North America Small Molecule CMO and CDMO Market Share by Country (2020-2031)

Figure 21. United States Small Molecule CMO and CDMO Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 22. Canada Small Molecule CMO and CDMO Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 23. Europe Small Molecule CMO and CDMO Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 24. Europe Small Molecule CMO and CDMO Market Share by Type (2020-2031)

Figure 25. Europe Small Molecule CMO and CDMO Market Share by Application (2020-2031)

Figure 26. Europe Small Molecule CMO and CDMO Market Share by Country (2020-2031)

Figure 27. Germany Small Molecule CMO and CDMO Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 28. France Small Molecule CMO and CDMO Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 29. U.K. Small Molecule CMO and CDMO Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 30. Italy Small Molecule CMO and CDMO Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 31. Russia Small Molecule CMO and CDMO Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 32. Nordic Countries Small Molecule CMO and CDMO Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 33. China Small Molecule CMO and CDMO Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 34. China Small Molecule CMO and CDMO Market Share by Type (2020-2031)

Figure 35. China Small Molecule CMO and CDMO Market Share by Application (2020-2031)

Figure 36. Asia Small Molecule CMO and CDMO Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 37. Asia Small Molecule CMO and CDMO Market Share by Type (2020-2031)

Figure 38. Asia Small Molecule CMO and CDMO Market Share by Application (2020-2031)

Figure 39. Asia Small Molecule CMO and CDMO Market Share by Region (2020-2031)

Figure 40. Japan Small Molecule CMO and CDMO Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 41. South Korea Small Molecule CMO and CDMO Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 42. China Taiwan Small Molecule CMO and CDMO Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 43. Southeast Asia Small Molecule CMO and CDMO Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 44. India Small Molecule CMO and CDMO Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 45. Australia Small Molecule CMO and CDMO Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 46. Middle East, Africa, and Latin America Small Molecule CMO and CDMO Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 47. Middle East, Africa, and Latin America Small Molecule CMO and CDMO Market Share by Type (2020-2031)

Figure 48. Middle East, Africa, and Latin America Small Molecule CMO and CDMO Market Share by Application (2020-2031)

Figure 49. Middle East, Africa, and Latin America Small Molecule CMO and CDMO Market Share by Country (2020-2031)

Figure 50. Brazil Small Molecule CMO and CDMO Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 51. Mexico Small Molecule CMO and CDMO Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 52. Turkey Small Molecule CMO and CDMO Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 53. Saudi Arabia Small Molecule CMO and CDMO Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 54. Israel Small Molecule CMO and CDMO Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 55. GCC Countries Small Molecule CMO and CDMO Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 56. Catalent Revenue Growth Rate in Small Molecule CMO and CDMO Business (2020-2025)

Figure 57. Thermo Fisher Scientific Revenue Growth Rate in Small Molecule CMO and CDMO Business (2020-2025)

Figure 58. Lonza Revenue Growth Rate in Small Molecule CMO and CDMO Business (2020-2025)

Figure 59. Siegfried Revenue Growth Rate in Small Molecule CMO and CDMO Business (2020-2025)

Figure 60. Recipharm Revenue Growth Rate in Small Molecule CMO and CDMO Business (2020-2025)

Figure 61. Boehringer Ingelheim Revenue Growth Rate in Small Molecule CMO and CDMO Business (2020-2025)

Figure 62. WuXi AppTech Revenue Growth Rate in Small Molecule CMO and CDMO Business (2020-2025)

Figure 63. WuXi Biologics Revenue Growth Rate in Small Molecule CMO and CDMO Business (2020-2025)

Figure 64. Fareva Revenue Growth Rate in Small Molecule CMO and CDMO Business (2020-2025)

Figure 65. Samsung Biologics Revenue Growth Rate in Small Molecule CMO and CDMO Business (2020-2025)

Figure 66. Aenova Revenue Growth Rate in Small Molecule CMO and CDMO Business (2020-2025)

Figure 67. Delpharm Revenue Growth Rate in Small Molecule CMO and CDMO Business (2020-2025)

Figure 68. Strides Pharma Revenue Growth Rate in Small Molecule CMO and CDMO Business (2020-2025)

Figure 69. Piramal Revenue Growth Rate in Small Molecule CMO and CDMO Business (2020-2025)

Figure 70. Famar Revenue Growth Rate in Small Molecule CMO and CDMO Business (2020-2025)

Figure 71. Curia Revenue Growth Rate in Small Molecule CMO and CDMO Business (2020-2025)

Figure 72. Jubilant Revenue Growth Rate in Small Molecule CMO and CDMO Business (2020-2025)

Figure 73. Vetter Revenue Growth Rate in Small Molecule CMO and CDMO Business (2020-2025)

Figure 74. AGC Pharma Chemicals Revenue Growth Rate in Small Molecule CMO and CDMO Business (2020-2025)

Figure 75. Asymchem Revenue Growth Rate in Small Molecule CMO and CDMO Business (2020-2025)

Figure 76. Porton Revenue Growth Rate in Small Molecule CMO and CDMO Business (2020-2025)

Figure 77. Eurofins Revenue Growth Rate in Small Molecule CMO and CDMO Business (2020-2025)

Figure 78. Ascendia Pharmaceuticals Revenue Growth Rate in Small Molecule CMO and CDMO Business (2020-2025)

Figure 79. Ardena Revenue Growth Rate in Small Molecule CMO and CDMO Business (2020-2025)

Figure 80. CPL Revenue Growth Rate in Small Molecule CMO and CDMO Business (2020-2025)

Figure 81. UPM Pharmaceuticals Revenue Growth Rate in Small Molecule CMO and CDMO Business (2020-2025)

Figure 82. FUJIFILM Diosynth Biotechnologies Revenue Growth Rate in Small Molecule CMO and CDMO Business (2020-2025)

Figure 83. Groupe Parima Revenue Growth Rate in Small Molecule CMO and CDMO Business (2020-2025)

Figure 84. TBD Pharmatech Revenue Growth Rate in Small Molecule CMO and CDMO Business (2020-2025)

Figure 85. Avid Bioservices Revenue Growth Rate in Small Molecule CMO and CDMO Business (2020-2025)

Figure 86. NextPharma Revenue Growth Rate in Small Molecule CMO and CDMO Business (2020-2025)

Figure 87. Alcami Revenue Growth Rate in Small Molecule CMO and CDMO Business (2020-2025)

Figure 88. Societal CDMO Revenue Growth Rate in Small Molecule CMO and CDMO Business (2020-2025)

Figure 89. MedPharm Revenue Growth Rate in Small Molecule CMO and CDMO Business (2020-2025)

Figure 90. Euroapi Revenue Growth Rate in Small Molecule CMO and CDMO Business (2020-2025)

Figure 91. BioVectra Revenue Growth Rate in Small Molecule CMO and CDMO Business (2020-2025)

Figure 92. Pfizer CentreOne Revenue Growth Rate in Small Molecule CMO and CDMO Business (2020-2025)

Figure 93. Fermion Revenue Growth Rate in Small Molecule CMO and CDMO Business (2020-2025)

Figure 94. Lundbeck Revenue Growth Rate in Small Molecule CMO and CDMO Business (2020-2025)

Figure 95. Bottom-up and Top-down Approaches for This Report

Figure 96. Data Triangulation

Figure 97. Key Executives Interviewed

Have a question?
Picture

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Picture

Christine Sirois

Manager - Americas

+1-860-674-8796

Questions? Please give us a call or visit the contact form.
Hi, how can we help?
Contact us!